A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer

Abstract

ss Open Acce Meeting abstract A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer Claudia Arce2, Carlos Perez-Plasencia1, Aurora Gonzalez-Fierro1, Erik de la Cruz-Hernandez1, Alma Revilla-Vazquez3, Alma Chavez-Blanco1, Catalina Trejo-Becerril1, Enrique Perez-Cardenas1, Lucia Taja-Chayeb1, Enrique Bargallo4, Patricia Villarreal4, Teresa Ramirez4, Teresa Vela5, Myrna Candelaria2, Maria F Camargo1, Elizabeth Robles2 and Alfonso Dueñas-Gonzalez*1

DOI: 10.1186/1471-2407-7-S1-A23

Extracted Key Phrases

Cite this paper

@article{Arce2007APS, title={A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer}, author={Claudia S Arce and Carlos G P{\'e}rez-Plasencia and Aurora Gonz{\'a}lez-Fierro and Erik de la Cruz-Hernandez and Alma Luisa Revilla-V{\'a}zquez and Alma D Ch{\'a}vez-Blanco and Catalina Trejo-Becerril and Enrique P{\'e}rez-C{\'a}rdenas and Luc{\'i}a Taja-Chayeb and E . Vinyoles Bargall{\'o} and Patricia Villarreal and Teresa J. Ramirez and Teresa A Vela and Myrna Candelaria and Maria F. Camargo and Elizabeth Robles and Alfonso Due{\~n}as-Gonz{\'a}lez}, journal={BMC Cancer}, year={2007}, volume={7}, pages={A23 - A23} }